Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Price

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Development, reliability, and validity of a new Preference and Satisfaction QuestionnaireDeborah T Gold, Rob Horne, Cheryl D Coon, et al.
Future Oncology (London, England)|February 7, 2023
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinibPaul K Paik, Ravi K Goyal, Beilei Cai, et al.
Journal of Neuroengineering and Rehabilitation|February 12, 2024
NSF DARE-transforming modeling in neurorehabilitation: a patient-in-the-loop frameworkJoshua G A Cashaback, Jessica L Allen, Amber Hsiao-Yang Chou, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatographyStephanie Ringeissen, Susan C Connor, H Roger Brown, et al.
Journal of Neuromuscular Diseases|November 18, 2016
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USAMark A Price, Victoria Barghout, Olivier Benveniste, et al.
Journal of Medicinal Chemistry|July 11, 2006
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potencyAlan D Borthwick, Dave E Davies, Anne M Exall, et al.
Journal of Medicinal Chemistry|February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of AsthmaKeith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Development, reliability, and validity of a new Preference and Satisfaction QuestionnaireDeborah T Gold, Rob Horne, Cheryl D Coon, et al.
Future Oncology (London, England)|February 7, 2023
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinibPaul K Paik, Ravi K Goyal, Beilei Cai, et al.
Journal of Neuroengineering and Rehabilitation|February 12, 2024
NSF DARE-transforming modeling in neurorehabilitation: a patient-in-the-loop frameworkJoshua G A Cashaback, Jessica L Allen, Amber Hsiao-Yang Chou, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatographyStephanie Ringeissen, Susan C Connor, H Roger Brown, et al.
Journal of Neuromuscular Diseases|November 18, 2016
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USAMark A Price, Victoria Barghout, Olivier Benveniste, et al.
Journal of Medicinal Chemistry|July 11, 2006
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potencyAlan D Borthwick, Dave E Davies, Anne M Exall, et al.
Journal of Medicinal Chemistry|February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of AsthmaKeith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Pageof 2